{"id":195,"date":"2020-05-29T11:44:48","date_gmt":"2020-05-29T02:44:48","guid":{"rendered":"https:\/\/gucvmed.med.gunma-u.ac.jp\/0_web\/?page_id=195"},"modified":"2020-05-29T11:44:48","modified_gmt":"2020-05-29T02:44:48","slug":"2015%e5%b9%b4%e5%ad%a6%e4%bc%9a%e7%99%ba%e8%a1%a8","status":"publish","type":"page","link":"https:\/\/gucvmed.med.gunma-u.ac.jp\/?page_id=195","title":{"rendered":"2015\u5e74\u5b66\u4f1a\u767a\u8868"},"content":{"rendered":"<section>\n<h4>\u7b2c235\u56de\u65e5\u672c\u5faa\u74b0\u5668\u5b66\u4f1a\u95a2\u6771\u7532\u4fe1\u8d8a\u5730\u65b9\u4f1a2015.2.7\uff08\u6771\u4eac\uff09<\/h4>\n<p>\u9f4b\u85e4\u771f\u8863\u3001\u8239\u7530\u7adc\u4e00\u3001\u9577\u8c37\u5ddd\u3000\u5bdb\u3001\u5f8c\u85e4\u6176\u5927\u3001\u5897\u7530\u304f\u306b\u5b50\u3001\u53cd\u753a\u79c0\u7f8e\u3001\u5c0f\u4fdd\u65b9\u3000\u512a\u3001\u4f50\u85e4\u4e07\u57fa\u4eba\u3001\u677e\u5c3e\u5f25\u679d\u3001\u4f50\u91ce\u5b8f\u548c\u3001\u9ad8\u9593\u5178\u660e\u3001\u7b20\u9593\u3000\u5468\u3001\u5c0f\u677f\u6a4b\u7d00\u901a\u3001\u5009\u6797\u6b63\u5f66<br \/>\n\u814e\u79fb\u690d\u5f8c\u306b\u76f8\u5bfe\u7684\u814e\u8840\u7ba1\u6027\u9ad8\u8840\u5727\u3092\u304d\u305f\u3057\u305f1\u4f8b<\/p>\n<\/section>\n<section>\n<h4>\u7b2c167\u56de\u65e5\u672c\u7d50\u6838\u75c5\u5b66\u4f1a\u95a2\u6771\u652f\u90e8\u5b66\u4f1a\u7b2c213\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u95a2\u6771\u5730\u65b9\u4f1a\u5408\u540c\u5b66\u4f1a\u30002015.2.14\uff08\u6771\u4eac\uff09<\/h4>\n<p>1\uff09\u4f50\u85e4\u9ebb\u91cc\u3001\u4e0a\u91ce\u3000\u5b66\u3001\u9577\u5ca1\u771f\u68a8\u5b50\u3001\u539f\u7530\u76f4\u4e4b\u3001\u76f8\u6fa4\u667a\u5f18\u3001\u6298\u5c45\u7f8e\u6ce2\u3001\u6e05\u6c34\u96c4\u81f3\u3001\u8302\u6728\u3000\u5145<br \/>\nPMX-DHP\u7642\u6cd5\u3092\u542b\u3081\u305f\u96c6\u5b66\u7684\u6cbb\u7642\u304c\u594f\u529f\u3057\u305fCADM\u5408\u4f75\u9593\u8cea\u6027\u80ba\u708e\u306e1\u4f8b<\/p>\n<p>2\uff09\u7247\u5c71\u5f69\u9999\u3001\u5c71\u53e3\u516c\u4e00\u3001\u5c71\u53e3\u3000\u5f69\u3001\u9234\u6728\u96c5\u6587\u3001\u5185\u7530\u3000\u6075\u3001\u539f\u3000\u5065\u4e00\u90ce\u3001\u9752\u6728\u3000\u671b\u3001\u795e\u6238\u5c06\u5f66\u3001\u5897\u6e15\u88d5\u6717\u3001\u9808\u8cc0\u9054\u592b\u3001\u524d\u91ce\u654f\u5b5d<br \/>\n\u5f93\u6765\u306e\u6cbb\u7642\u6cd5\u306b\u30ea\u30c4\u30ad\u30b7\u30de\u30d6\u3092\u52a0\u3048\u3066\u52a0\u7642\u3057\u305fCADM\u306b\u5408\u4f75\u3057\u305f\u6025\u901f\u9032\u884c\u6027\u9593\u8cea\u6027\u80ba\u708e\u306e1\u4f8b<\/p>\n<\/section>\n<section>\n<h4>\u7b2c612\u56de\u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u95a2\u6771\u5730\u65b9\u4f1a\u30002015.2.14\uff08\u6771\u4eac\uff09<\/h4>\n<p>\u9ad8\u702c\u4eae\u592a\u3001\u6e05\u6c34\u96c4\u81f3\u3001\u4f50\u85e4\u9ebb\u91cc\u3001\u539f\u7530\u76f4\u4e4b\u3001\u76f8\u6fa4\u667a\u5f18\u3001\u6298\u5c45\u7f8e\u6ce2\u3001\u4e0a\u91ce\u3000\u5b66\u3001\u8302\u6728\u3000\u5145<br \/>\nEGFR-TKI\u306b\u3088\u308b\u85ac\u5264\u6027\u9593\u8cea\u6027\u80ba\u708e\u3068\u306e\u9451\u5225\u3092\u8981\u3057\u305f\u80ba\u30af\u30ea\u30d7\u30c8\u30b3\u30c3\u30ab\u30b9\u75c7\u306e1\u4f8b<\/p>\n<\/section>\n<section>\n<h4>\u7b2c26\u56de\u3000\u65e5\u672c\u5fc3\u30a8\u30b3\u30fc\u56f3\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30002015.3.26-28\uff08\u5317\u4e5d\u5dde\uff09<\/h4>\n<p>1\uff09\u53cd\u753a\u79c0\u7f8e\u3001\u6839\u5cb8\u4e00\u660e\u3001\u9ed2\u6ca2\u5e78\u55e3\u3001\u5c0f\u4fdd\u65b9\u512a\u3001\u5409\u7530\u304f\u306b\u5b50\u3001\u4e39\u4e0b\u6b63\u4e00\u3001\u5009\u6797\u6b63\u5f66<br \/>\n\u5de6\u5ba4\u5f1b\u7de9\u80fd\u3068\u5e74\u9f62\u30fb\u5f8c\u8ca0\u8377\u306e\u76f8\u95a2\u306b\u306f\u6709\u610f\u306a\u6027\u5dee\u304c\u3042\u308b<\/p>\n<p>2\uff09\u5c0f\u4fdd\u65b9\u512a\u3001\u6839\u5cb8\u4e00\u660e\u3001\u9ed2\u6ca2\u5e78\u55e3\u3001\u77f3\u7530\u79c0\u5c90\u3001\u4f0a\u85e4\u606d\u5b50\u3001\u5c0f\u5ddd\u54f2\u4e5f\u3001\u5b89\u85e4\u7fa9\u5b5d\u3001\u5009\u6797\u6b63\u5f66<br \/>\nExercise-induced afterload mismatch after longer inter-dialytic interval in patients receiving hemodialysis<\/p>\n<p>3\uff09\u5409\u7530\u304f\u306b\u5b50\u3001\u5c0f\u4fdd\u65b9\u512a\u3001\u6839\u5cb8\u4e00\u660e\u3001\u9ed2\u6ca2\u5e78\u55e3\u3001\u53cd\u753a\u79c0\u7f8e\u3001\u5009\u6797\u6b63\u5f66<br \/>\nSex Differences in Left Atrial Strain and its Relationship to CHADS2 Score in Patients with Atrial Fibrillation<\/p>\n<p>4\uff09\u5ca1\u7530\u9855\u4e5f\u3001\u9ed2\u6ca2\u5e78\u55e3\u3001\u9ad8\u7530\u667a\u5b50\u3001\u4e39\u7fbd\u52a0\u5948\u5b50\u3001\u751f\u99d2\u5353\u5b8f\u3001\u753a\u7530\u54f2\u592b\u3001\u5009\u6797\u6b63\u5f66\u3001\u6751\u4e0a\u6b63\u5df3<br \/>\n\u611f\u67d3\u6027\u5fc3\u5185\u819c\u708e\u306b\u5bfe\u3059\u308b\u5916\u79d1\u6cbb\u7642\u5f8c\u3001\u5de8\u5927\u5de6\u5ba4\u4eee\u6027\u7624\u3092\u5f62\u6210\u3057\u305f\u4e00\u4f8b<\/p>\n<p>5\uff09\u9ed2\u6ca2\u5e78\u55e3\u3001\u6839\u5cb8\u4e00\u660e\u3001\u53cd\u753a\u79c0\u7f8e\u3001\u5897\u7530\u304f\u306b\u5b50\u3001\u5c0f\u4fdd\u65b9\u512a\u3001\u5009\u6797\u6b63\u5f66<br \/>\n\u5de6\u623f\u5929\u4e95\u90e8\u5206\u3092\u9664\u3044\u305f\u5de6\u623f\u30b9\u30c8\u30ec\u30a4\u30f3\u306f\u3001\u5168\u5206\u753b\u306e\u5de6\u623f\u30b9\u30c8\u30ec\u30a4\u30f3\u3068\u6bd4\u3079CHADS2\u30b9\u30b3\u30a2\u3068\u3088\u308a\u5f37\u304f\u76f8\u95a2\u3059\u308b\u50be\u5411\u306b\u3042\u308b<\/p>\n<p>6\uff09\u52a0\u85e4\u5bff\u5149\u3001\u9ed2\u6ca2\u5e78\u55e3\u3001\u85cd\u539f\u548c\u53f2\u3001\u6749\u6238\u7fa9\u52dd\u3001\u702c\u7530\u4eab\u535a\u3001\u91d1\u5b50\u514b\u5df1\u3001\u5009\u6797\u6b63\u5f66<br \/>\n3\u6b21\u5143\u7d4c\u98df\u9053\u5fc3\u30a8\u30b3\u30fc\u56f3\u691c\u67fb\u3067\u89b3\u5bdf\u3057\u5f97\u305f\u50e7\u5e3d\u5f01\u5f62\u6210\u8853\u5f8c\u6162\u6027\u671f\u306b\u9032\u884c\u3057\u305f\u6eb6\u8840\u6027\u8ca7\u8840\u306e1\u4f8b<\/p>\n<\/section>\n<section>\n<h4>\u7b2c55\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30002015.4.17-19\uff08\u6771\u4eac\uff09<\/h4>\n<p>1\uff09\u5c0f\u6fa4\u53cb\u91cc\u3001\u539f\u3000\u5065\u4e00\u90ce\u3001\u5185\u7530\u3000\u6075\u3001\u9234\u6728\u96c5\u6587\u3001\u5c71\u53e3\u516c\u4e00\u3001\u5c71\u53e3\u3000\u5f69\u3001\u5897\u6e15\u88d5\u6717\u3001\u795e\u6238\u5c06\u5f66\u3001\u9752\u6728\u3000\u671b\u3001\u524d\u91ce\u654f\u5b5d\u3001\u5009\u6797\u6b63\u5f66<br \/>\n\u5358\u7d50\u7bc0\u578b\u80ba\u91ce\u75c5\u5909\u3092\u5448\u3057\u305f\u30b5\u30eb\u30b3\u30a4\u30c9\u30fc\u30b7\u30b9\u306e\u81e8\u5e8a\u7684\u691c\u8a0e<\/p>\n<p>2\uff09\u9234\u6728\u96c5\u6587\u3001\u539f\u3000\u5065\u4e00\u90ce\u3001\u5c71\u53e3\u516c\u4e00\u3001\u5185\u7530\u3000\u6075\u3001\u5c71\u53e3\u3000\u5f69\u3001\u5897\u6e15\u88d5\u6717\u3001\u795e\u6238\u5c06\u5f66\u3001\u9752\u6728\u3000\u671b\u3001\u524d\u91ce\u654f\u5b5d\u3001\u5009\u6797\u6b63\u5f66<br \/>\n\u5f37\u76ae\u75c7\u306b\u5408\u4f75\u3057\u305f\u9593\u8cea\u6027\u80ba\u708e\u306e\u81e8\u5e8a\u7684\u691c\u8a0e<\/p>\n<p>3\uff09\u5c71\u53e3\u516c\u4e00\u3001\u9234\u6728\u96c5\u6587\u3001\u5185\u7530\u3000\u6075\u3001\u5c71\u53e3\u3000\u5f69\u3001\u5897\u6e15\u88d5\u6717\u3001\u795e\u6238\u5c06\u5f66\u3001\u539f\u3000\u5065\u4e00\u90ce\u3001\u9752\u6728\u3000\u671b\u3001\u524d\u91ce\u654f\u5b5d\u3001\u9808\u8cc0\u9054\u592b\u3001\u5009\u6797\u6b63\u5f66<br \/>\n\u547c\u5438\u5668\u75be\u60a3\u60a3\u8005\u306b\u304a\u3051\u308b\u8840\u6e05\u30aa\u30b9\u30c6\u30aa\u30d7\u30ed\u30c6\u30b8\u30a7\u30ea\u30f3\u6e2c\u5b9a\u306e\u6709\u7528\u6027\u306e\u691c\u8a0e<\/p>\n<p>4\uff09\u5185\u7530\u3000\u6075\u3001\u9234\u6728\u96c5\u6587\u3001\u5c71\u53e3\u516c\u4e00\u3001\u5c71\u53e3\u3000\u5f69\u3001\u5897\u6e15\u88d5\u6717\u3001\u539f\u3000\u5065\u4e00\u90ce\u3001\u9752\u6728\u3000\u671b\u3001\u524d\u91ce\u654f\u5b5d\u3001\u9808\u8cc0\u9054\u592b\u3001\u5009\u6797\u6b63\u5f66<br \/>\n\u5faa\u74b0\u5668\u75be\u60a3\u3092\u5408\u4f75\u3057\u305fCOPD\u60a3\u8005\u306e\u6cbb\u7642\u306b\u95a2\u3059\u308b\u691c\u8a0e<\/p>\n<p>5\uff09\u7247\u5c71\u5f69\u9999\u3001\u5c71\u53e3\u3000\u5f69\u3001\u9752\u6728\u3000\u671b\u3001\u5185\u7530\u3000\u6075\u3001\u9234\u6728\u96c5\u6587\u3001\u5c71\u53e3\u516c\u4e00\u3001\u5897\u6e15\u88d5\u6717\u3001\u795e\u6238\u5c06\u5f66\u3001\u539f\u3000\u5065\u4e00\u90ce\u3001\u524d\u91ce\u654f\u5b5d\u3001\u5009\u6797\u6b63\u5f66<br \/>\nClinically amyopathic dermatomyositis\u306b\u4f34\u3046\u9593\u8cea\u6027\u80ba\u708e\u306e\u81e8\u5e8a\u7684\u691c\u8a0e<\/p>\n<p>6\uff09\u7530\u53e3\u6d69\u5e73\u3001\u9752\u6728\u5eb7\u5f18\u3001\u5009\u5cf6\u512a\u7406\u4e9c\u3001\u7af9\u6751\u4ec1\u7537\u3001\u795e\u6238\u5c06\u5f66\u3001\u539f\u3000\u53f2\u90ce\u3001\u9808\u8cc0\u9054\u592b\u3001\u524d\u91ce\u654f\u5b5d\u3001\u5009\u6797\u6b63\u5f66<br \/>\n\u3044\u3073\u304d\u60a3\u8005\u306b\u304a\u3051\u308b\u9589\u585e\u6027\u7761\u7720\u6642\u7121\u547c\u5438\u75c7\u5019\u7fa4\u306e\u691c\u8a0e<\/p>\n<p>7\uff09\u5009\u5cf6\u512a\u7406\u4e9c\u3001\u9752\u6728\u5eb7\u5f18\u3001\u7af9\u6751\u4ec1\u7537\u3001\u795e\u6238\u5c06\u5f66\u3001\u539f\u3000\u53f2\u90ce\u3001\u9808\u8cc0\u9054\u592b\u3001\u524d\u91ce\u654f\u5b5d\u3001\u5009\u6797\u6b63\u5f66<br \/>\n\u5f53\u9662\u306e\u9589\u585e\u6027\u7761\u7720\u6642\u7121\u547c\u5438\u75c7\u5019\u7fa4\u60a3\u8005\u306b\u304a\u3051\u308bPSG\u3092\u7528\u3044\u305f\u518d\u8a55\u4fa1\u4f8b\u306e\u691c\u8a0e<\/p>\n<p>8\uff09\u9ad8\u702c\u4eae\u592a\u3001\u6e05\u6c34\u96c4\u81f3\u3001\u539f\u7530\u76f4\u4e4b\u3001\u4f50\u85e4\u9ebb\u91cc\u3001\u76f8\u6fa4\u667a\u5f18\u3001\u6298\u5c45\u7f8e\u6ce2\u3001\u4e0a\u91ce\u3000\u5b66\u3001\u8302\u6728\u3000\u5145\u3001\u9234\u6728\u96c5\u6587\u3001\u5897\u6e15\u88d5\u6717\u3001\u539f\u3000\u5065\u4e00\u90ce\u3001\u524d\u91ce\u654f\u5b5d\u3001\u9808\u8cc0\u9054\u592b\u3001\u5009\u6797\u6b63\u5f66<br \/>\nCOPD\u547c\u5438\u6a5f\u80fd<\/p>\n<p>9\uff09\u4e0a\u91ce\u3000\u5b66\u3001\u524d\u91ce\u654f\u5b5d\u3001\u5897\u6e15\u88d5\u6717\u3001\u539f\u3000\u5065\u4e00\u90ce\u3001\u539f\u7530\u76f4\u4e4b\u3001\u76f8\u6fa4\u667a\u5f18\u3001\u6e05\u6c34\u96c4\u81f3\u3001\u8302\u6728\u3000\u5145\u3001\u9808\u8cc0\u9054\u592b\u3001\u5009\u6797\u6b63\u5f66<br \/>\n\u80ba\u6c17\u816b\u30e2\u30c7\u30eb\u30de\u30a6\u30b9\u306b\u304a\u3051\u308b\u30de\u30af\u30ed\u30d5\u30a1\u30fc\u30b8\u708e\u75c7\u306b\u5bfe\u3059\u308balendronate\u5438\u5165\u7642\u6cd5\u306e\u6709\u52b9\u6027<\/p>\n<p>10\uff09\u77f3\u5ddd\u5927\u4ecb\u3001\u8302\u6728\u3000\u5145\u3001\u76f8\u6fa4\u667a\u5f18\u3001\u539f\u7530\u76f4\u4e4b\u3001\u4f50\u85e4\u9ebb\u91cc\u3001\u6298\u5c45\u7f8e\u6ce2\u3001\u4e0a\u91ce\u3000\u5b66\u3001\u6e05\u6c34\u96c4\u81f3\u3001\u4e2d\u5ddd\u7d14\u4e00\u3001\u585a\u8d8a\u6b63\u7ae0\u3001\u5897\u6e15\u88d5\u6717\u3001\u539f\u3000\u5065\u4e00\u90ce\u3001\u524d\u91ce\u654f\u5b5d\u3001\u9808\u8cc0\u9054\u592b\u3001\u5009\u6797\u6b63\u5f66<br \/>\n\u30b9\u30c6\u30ed\u30a4\u30c9\u6cbb\u7642\u4e2d\u306b\u767a\u75c7\u3057\u305f\u30cb\u30e5\u30fc\u30e2\u30b7\u30b9\u30c1\u30b9\u80ba\u708e\uff08PCP\uff09\u306e\u81e8\u5e8a\u7684\u691c\u8a0e <\/p>\n<p>11\uff09\u539f\u7530\u76f4\u4e4b\uff0c\u8302\u6728\u3000\u5145\uff0c\u4f50\u85e4\u9ebb\u91cc\uff0c\u76f8\u6fa4\u667a\u5f18\uff0c\u6298\u5c45\u7f8e\u6ce2\uff0c\u4e0a\u91ce\u3000\u5b66\uff0c\u6e05\u6c34\u96c4\u81f3\uff0c\u524d\u91ce\u654f\u5b5d<\/p>\n<p>\u96c6\u5b66\u7684\u6cbb\u7642\u306b\u3088\u308b\u5bdb\u89e3\u5c0e\u5165\u5f8c\u306b\u8840\u6db2\u60aa\u6027\u75be\u60a3\u3092\u4f75\u767a\u3057\u305f\u7e26\u9694\u578b\u60aa\u6027\u80da\u7d30\u80de\u6027\u816b\u760d\u306e2\u4f8b<br \/>\n12\uff09\u9ad8\u702c\u4eae\u592a\uff0c\u6e05\u6c34\u96c4\u81f3\uff0c\u539f\u7530\u76f4\u4e4b\uff0c\u4f50\u85e4\u9ebb\u91cc\uff0c\u76f8\u6fa4\u667a\u5f18\uff0c\u6298\u5c45\u7f8e\u6ce2\uff0c\u4e0a\u91ce\u3000\u5b66\uff0c\u8302\u6728\u3000\u5145\uff0c\u524d\u91ce\u654f\u5b5d<br \/>\n\u6804\u990a\u7642\u6cd5\u3092\u91cd\u8996\u3057\u305fCOPD\u5730\u57df\u9023\u643a\u30d1\u30b9\u306e\u5c0e\u5165\u3068\u305d\u306e\u610f\u7fa9<\/p>\n<\/section>\n<section>\n<h4>\u7b2c79\u56de\u65e5\u672c\u5faa\u74b0\u5668\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30002015.4.24-26\uff08\u5927\u962a\uff09<\/h4>\n<p>1\uff09Kumakura H,Kanai H,Araki Y,Iwasaki T,Takayama Y,Ichikawa S,Kasama S,Kurabayashi M.<br \/>\nRisk Factors for Systemic Atherosclerosis and Fate of Claudication in Patients with Peripheral Arterial Disease<\/p>\n<p>2\uff09Takama N,Obokata M,Sato M,Sano H,Matsuo Y,Kasama S,Koitabashi N,Kato T,Kurabayashi M.<br \/>\nAdaptive Servo Ventilation Therapy for Stage D Heart Failure Patients<\/p>\n<p>3\uff09<Finalist of YIA\u201dClinical Research\u201d><br \/>\n Obokata M,Ohyama Y,Iso T,Kawaguchi T,Sunaga H, Koitabashi N, Mr Syamsunarno,Murata M,Funada R,Takama N,Matsui H,Yokoyama T,Murakami M,Kurabayashi M.<br \/>\nEarly Increase in Circulating Fatty Acid Binding Protein 4 Levels in Patients with Acute Myocardial Infarction: Lipolysis as a novel marker for myocardial ischemia<\/p>\n<p>4\uff09Seki M,Koitabashi N,Sunaga H,Arakawa H, Kurabayashi M.<br \/>\nPeriostin Expressing Cell and Its Transfroming Growth Factor-\u03b2 Signaling are Involved with Progression of Pulmonary Arterial Hypertension in Mice<\/p>\n<p>5\uff09Ono Y,Nakajima T,Kaneko Y,Saitoh A,Imai M,Irie T,Ohta M,Iijima T,Hunada R,Takama N,Nakamura K,Seta Y,Kaneko K,Hiroi S,Niwamae N,Inoue M,Tange S,Kurabayashi M.<br \/>\nClinical and Genetic Backgrounds of Fatal Arrhythmias Associated with Vasospastic Angina<\/p>\n<p>6\uff09Mas R.A.A Syamsunarno,Iso T,Koitabashi N,Kurabayashi M.<br \/>\nDeletion of Fatty Acid Binding Protein 4\/5 Exacerbate Cardiac Dysfunction Due to Insufficient ATP Production during Pressure Overload in Mice<\/p>\n<p>7\uff09Kato T,Takama N,Aihara K,Tamura M,Sugito M,Seta Y,Kaneko K,Kurabayashi M<br \/>\nNew Pretherapeutic Diagnostic Criteria to Predict Response to Adaptive Servo Ventilation in Patient with Heart Failure<\/p>\n<p>8\uff09Obokata M,Iso T,Sunaga H,Iijima T,Ota M,Ohyama Y,Funada R,Takama N,Kasama S,Koitabashi N,Nakajima T,Kaneko Y,Kurabayashi M<br \/>\nFatty Acid-Binding Protein 5 as a Marker for Acute Myocardial Infarction<\/p>\n<p>9\uff09Nakajima T, Kaneko Y,Masuda K,Iijima T,Ohta M,Kurabayashi M.<br \/>\nNovel SCN5A-P621H Mutation Associated with Long QT Syndrome and Left-Bundle-Branch-Block Myopathy<\/p>\n<p>10\uff09Kasama S,Sato M,Sano H,Hasegawa H,Goto K,Koike Y,Sorimachi H,Masuda K,Obokata M,Matsuo Y,Kurosawa K,Funada R,Takama N,Koitabashi N,Kurabayashi M<br \/>\nImmediate Administration of Selective Aldosterone Blocker Eplerenone Improves Sympathetic Nerve Activity after Reperfusion Therapy in Patients with Acute Myocardial Infarction<\/p>\n<p>11\uff09Kasama S,Sato M,Sano H,Hasegawa H,Goto K,Koike Y,Sorimachi H,Masuda K,Obokata M,Matsuo Y,Kurosawa K,Funada R,Takama N,Koitabashi N,Kurabayashi M<br \/>\nEffects of Statin on Sympathetic Nerve Activity and Incidence of Major Adverse Cardiac Events in ST-Segment Elevation Myocardial Infarction Patients<\/p>\n<p>12\uff09Kaneko Y,Suzuki F,Naitoh S,Okishige K,Morishima I,Tobiume T,Nakajima T,Irie T,Ohta M,Iijima T,Katoh R,Matsumoto K,Kurabayashi  M.<br \/>\nElectrophysiological Characteristics of Anterior Slow Pathway<\/p>\n<p>13\uff09Sato M,Kasama S,Sano H,Hasegawa H,Goto K,Koike Y,Sorimachi H,Masuda K,Obokata M,Matsuo Y,Kurosawa K,Funada R,Takama N,Koitabashi N,Kurabayashi M<br \/>\nComparative Effects of Long and Short-Acting Loop Diuretics on Sympathetic Nerve Activity in Chronic Heart Failure Patients: A Propensity Score-matched Analysis<\/p>\n<p>14\uff09Sano H,Kasama S,Sato M,Hasegawa H,Goto K,Koike Y,Sorimachi H,Masuda K,Obokata M,Matsuo Y,Kurosawa K,Funada R,Takama N,Koitabashi N,Kurabayashi M.<br \/>\nStatin Therapy Improves Cardiac Sympathetic Nerve Activity and Prevents Cardiac Events in Patients with Chronic Heart Failure: A Propensity Score-matched Analysis<\/p>\n<p>15\uff09Koitabashi N,Yamamoto M,Musashi T,Imamura H,Kurabayashi M.<br \/>\nIn Vivo Visualization of ATP Levels Reveals a New World of Cardiac Physiology<\/p>\n<p>16\uff09Kaneko Y,Nakajima T,Irie T,Ohta M,Iijima T,Tamura M,Iizuka T,Tamura S,Kobayashi H,Saitoh A,Kurabayasi M.<br \/>\nAntidromic Resetting in Fast-Slow Atrioventricular Nodal Reentrant Tachycardia: Atrial Entrainment Pacing May Accelerate Subsequent Retrograde Conduction over Slow Pathway<\/p>\n<p>17\uff09Kasama S,Sano H,Hasegawa H,Goto K,Koike Y,Sorimachi H,Masuda K,Obokata M,Matsuo Y,Kurosawa K,Funada R,Takama N,Kurabayashi M.<br \/>\nEffects of Rosuvastatin on Sympathetic Nerve Activity after Reperfusion Therapy in Patients with ST-segment-Elevation Myocardial Infarction and Normal Low-Density-Lipoprotein Cholesterol<\/p>\n<p>18\uff09Kasama S,Sato M,Sano H,Hasegawa H,Goto K,Koike Y,Sorimachi H,Masuda K,Obokata M,Kurosawa K,Funada R,Takama N,Koitabashi N,Kurabayashi M.<br \/>\nSerial Dual SPECT of 201Tl\/123I-BMIPP Can Predict Functional Recovery after Coronary Artery Bypass Grafting in Coronary Artery Disease Patients<\/p>\n<p>19\uff09Koitabashi N,Yogi U,Obokata M,Mas R.A.A.Syamsunarno,Yamaguchi A,Kurabayashi M.<br \/>\nVildagliptin Attenuates Cardiac Hypertrophy and Improves Ventricular Efficiency in Pressure-overloaded Mouse Heart<\/p>\n<p>20\uff09Yogi Umbarawan,Iso T,Mas R.A.A Syamsunarno,Koitabashi N,Kurabayashi M<br \/>\nImpaired Fatty Acid Utilization Exacerbates Cardiac Dysfunction under Septic Condition in Mice Lacking Both Fatty Acid Binding Protein 4\/5<\/p>\n<p>21\uff09Mas R.A.A Syamsunarno,Iso T,Kurabayashi M.<br \/>\nDeficiency of Fatty Acid Binding Protein-4 and -5 Impairs Lipid Absorption in Mice<\/p>\n<p>22\uff09Mas R.A.A Syamsunarno,Iso T,Mirasari Putri,Kurabayashi M.<br \/>\nFatty Acid Translocase (FAT\uff09\/CD36 Plays Crucial Role in Thermogenesis under Cold Exposure during Fasting in Mice<\/p>\n<p>23\uff09Obokata M,Iso T,Sunaga H,Iijima T,Ota M,Ohyama Y,Funada R,Takama N,Kasama S,Koitabashi N,Nakajima T,Kaneko Y,Kurabayashi M.<br \/>\nRelationship between Circulating FABP4 and Heart Rate in the Patients with Heart Failure<\/p>\n<p>24\uff09Niijima K,Obokata M,Kurabayashi M.<br \/>\nPrevalence of Paroxysmal Atrial Fibrillation (PAF\uff09and Its Risk Factors in the Patients with Cardiovascular Disease without Previously Recognized AF<\/p>\n<p>25\uff09Tamura S,Kaneko Y,Nakahara S,Morishima I,Takenaka S,Nakajima T,Irie T,Ohta M,Iijima T,Tamura M,iiduka T,Kobayashi H,Saitoh A,Kurabayashi M.<br \/>\nExtensive Scar in Right Atrial Free Wall is Associated with Development of Upper Loop Re-entry<\/p>\n<p>26\uff09NagasakaT,Takama N,Kurabayashi M.<br \/>\nAdaptive Servo-Ventilation Therapy Shows Significant Improvement of Prognosis in Patients with Heart Failure<\/p>\n<p>27\uff09Kanai H,Kumakura H,Hojo Y,Arakai Y,Kasama S,Iwasaki T,Takayama Y,Minami K,Ichikawa S,Kurabayashi M.<br \/>\nFifteen-Year Patency and Factors Causing Restenosis after Endovascular Treatment with Direct Stenting in Iliac Artery Lesions<\/p>\n<p>28\uff09Kasama S,Sato M,Sano H,Hasegawa H,Goto K,Koike Y,Sorimachi H,Masuda K,Obokata M,Matsuo Y,Kurosawa K,Funada R,Takama N,Koitabashi N,Kurabayashi M.<br \/>\nPrognostic Value of Myocardial Perfusion SPECT for Major Adverse Cardiac Cerebrovascular and Renal Events among Patients with Chronic Kidney Disease<\/p>\n<p>29\uff09Naganuma F,Kurabayashi M,Kamiyama H,Okamoto E,Nagumo I,Hosoi T,Yamaguchi E,Tsurugaya H.<br \/>\nComparison of Variability and Effect Levels of Coagulation Assays Data among Apixaban, Dabigatran and Rivaroxaban<\/p>\n<p>30\uff09Iizuka T,Kaneko Y,Nakajima T,Irie T,Ohta M,Iijima T,Tamura M,Tamura S,Kobayashi H,Saitoh A,Kurabayashi M.<br \/>\nDetection of qrS Morphology of Unipolar Potential during Mapping of Idiopathic Ventricular Tachyarrhythmias is Indicative of the Intramural Origin<\/p>\n<p>31\uff09Sano H,Kasama S,Sato M,Hasegawa H,Goto K,Koike Y,Sorimachi H,Masuda K,Obokata M,Matsuo Y,Kurosawa K,Funada R,Takama N,Koitabashi N,Kurabayashi M.<br \/>\nEffects of Statin Therapy on Sympathetic Nerve Activity and Left Ventricular Remodeling in Chronic Heart Failure Patients: A Propensity Score-Matched Analysis<\/p>\n<p>32\uff09Kasama S,Sato M,Sano H,Hasegawa H,Goto K,Koike Y,Sorimachi H,Masuda K,Obokata M,Matsuo Y,Kurosawa K,Funada R,Takama N,Koitabashi N,Kurabayashi M.<br \/>\nSerial 123I-Metaiodobenzylguanidine Studies are More Useful for Predicting Sudden Cardiac Death than One-time Scan in Stabilized Chronic Heart Failure Patients<\/p>\n<p>33\uff09Ono Y, Nakajima T, Kaneko Y, Saito A, Imai M, Irie T, Ota M, Iijima T, Funada R, Takama N, Nakamura K, Seta Y, Kaneko K, Hiroi S, Niwamae N, Inoue M, Tange S, Kurabayashi M.<br \/>\nClinical and Genetic Backgrounds of Fatal Arrhythmias Associated with Vasospastic Angina<\/p>\n<\/section>\n<section>\n<h4>\u7b2c46\u56de\u65e5\u672c\u5fc3\u8840\u7ba1\u30a4\u30f3\u30bf\u30fc\u30d9\u30f3\u30b7\u30e7\u30f3\u6cbb\u7642\u5b66\u4f1a\u95a2\u6771\u7532\u4fe1\u8d8a\u5730\u65b9\u4f1a\uff08\u6771\u4eac\uff092015.5.9<\/h4>\n<p>\u8239\u7530\u7adc\u4e00<br \/>\nRCA\u5b8c\u5168\u9589\u585e\u306b\u5bfe\u3059\u308bretrograde apparoch\u306e\u969b\u306bLAD\u306b\u62e1\u5f35\u3057\u305f\u30d0\u30eb\u30fc\u30f3\u304c\u7834\u88c2\u3057\u3001\u9006\u884c\u6027\u4e56\u96e2\u304cLMT\u307e\u3067\u53ca\u3093\u3060\u4e00\u75c7\u4f8b<\/p>\n<\/section>\n<section>\n<h4>Heart Rhythm Society\u2019s 36th Annual Scientific Sessions,\u30002015.5.13-16\uff08Boston\uff09<\/h4>\n<p>1\uff09Kaneko Y,Naito S,Okishige K,Morishima I,Tobiume T,Nakajima T,Irie T,Kato R,Matsumoto K,Suzuki F,Kurabayashi M.<br \/>\nAtypical fast-slow atrioventricular nodal reentrant tachycardia incorporating \u201canterior\u201dslow pathway: A proposal of a distinct tachycardia entity. <\/p>\n<p>2\uff09Kaneko Y,Nakajima T,Irie T,Ota M,Iijima T,Kurabayashi M.<br \/>\nAntidromically-modified orthodromic resetting by atrial depolarization in fast-slow atrioventricular nodal reentrant tachycardia. <\/p>\n<\/section>\n<section>\n<h4>\u7b2c40\u56de\u65e5\u672c\u8d85\u97f3\u6ce2\u691c\u67fb\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30002015.5.15-17\uff08\u6a2a\u6d5c\uff09<\/h4>\n<p>1\uff09\u4e39\u6ce2\u52a0\u5948\u5b50\u3001\u9ad8\u7530\u667a\u5b50\u3001\u9ed2\u6ca2\u5e78\u55e3\u3001\u68ee\u7530\u572d\u5b50\u3001\u751f\u99d2\u5353\u5b8f\u3001\u5ca1\u7530\u9855\u4e5f\u3001\u9759\u3000\u601c\u5b50\u3001\u89d2\u91ce\u535a\u4e4b\u3001\u753a\u7530\u54f2\u7537\u3001\u6751\u4e0a\u6b63\u5df3<br \/>\n\u91cd\u75c7\u80ba\u9ad8\u8840\u5727\u75c7\u306b\u3082\u3042\u3063\u304b\u308f\u3089\u305a\u5de6\u5ba4\u4e2d\u9694D-shape\u304c\u8efd\u5ea6\u3067\u3042\u3063\u305f\u9650\u5c40\u578b\u5168\u8eab\u5f37\u76ae\u75c7\u306e\u4e00\u4f8b<\/p>\n<p>2\uff09\u6709\u99ac\u3072\u3068\u307f\u3001\u9ed2\u6ca2\u5e78\u55e3\u3001\u677e\u5c3e\u7f8e\u667a\u5b50\u3001\u77f3\u5009\u9806\u5b50\u3001\u4e45\u4fdd\u7530\u6df3\u5b50\u3001\u5e83\u6e05\u4e45\u7f8e\u3001\u7d30\u898b\u967d\u5b50\u3001\u6797\u3000\u5f18\u6a39\u3001\u77f3\u5ddd\u548c\u5fb3\u3001\u68ee\u3000\u79c0\u6681<br \/>\n\u7570\u306a\u308b\u30a8\u30b3\u30fc\u50cf\u3092\u5448\u3057\u305f\u53f3\u623f\u8840\u6db2\u56a2\u816b\u306e2\u4f8b<\/p>\n<\/section>\n<section>\n<h4>\u7b2c214\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u95a2\u6771\u5730\u65b9\u4f1a\u30002015.5.23 \uff08\u6771\u4eac\uff09<\/h4>\n<p>\u4e95\u4e0a\u7950\u592a\u3001\u5c71\u53e3\u516c\u4e00\u3001\u5c71\u53e3\u3000\u5f69\u3001\u539f\u3000\u5065\u4e00\u90ce\u3001\u9234\u6728\u96c5\u6587\u3001\u5185\u7530\u3000\u6075\u3001\u5927\u5cf6\u4e00\u771f\u3001\u5897\u6e15\u88d5\u6717\u3001\u6885\u6d25\u548c\u6075\u3001\u524d\u91ce\u654f\u5b5d\u3001\u9808\u8cc0\u9054\u592b<br \/>\n\u6297 MDA5 \u6297\u4f53\u967d\u6027 clinically amyopathic dermatomyositis\uff08CADM\uff09\u306b\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u3001\u80f8\u819c\u708e\u306e\u5408\u4f75\u3092\u8a8d\u3081\u305f\u4e00\u4f8b <\/p>\n<\/section>\n<section>\n<h4>\u7b2c58\u56de\u65e5\u672c\u7cd6\u5c3f\u75c5\u5b66\u4f1a\u5e74\u6b21\u5b66\u8853\u96c6\u4f1a\u30002015.5.21-24\uff08\u4e0b\u95a2\uff09<\/h4>\n<p>1\uff09\u5b87\u90fd\u6728\u654f\u6d69\u3001\u4e2d\u91ce\u771f\u5f13\u3001\u798f\u7530\u4e09\u667a\u4ee3\u3001\u7530\u4e2d\u771f\u7d00\u5b50\u3001\u9577\u8c37\u5ddd\u65e9\u4ee3\u3001\u5973\u5c4b\u7531\u7f8e\u3001\u8a2d\u697d\u512a\u9999<br \/>\n\u9ad8\u9f62\u8005\u7cd6\u5c3f\u75c5\u75c7\u4f8b\u306b\u304a\u3051\u308b\u7c21\u6613\u578b\u8a8d\u77e5\u6a5f\u80fd\u30c6\u30b9\u30c8\u306b\u3088\u308b\u5b9f\u614b\u8abf\u67fb<\/p>\n<p>2\uff09\u5927\u6d25\u7fa9\u6643\u3001\u548c\u7530\u7dbe\u3001\u4eca\u4e95\u6717\u3001\u5009\u7530\u52a0\u5948\u5b50\u3001\u9ad8\u6a4b\u821e\u3001\u5927\u9808\u8cc0\u7a14\u6a39\u3001\u5c0f\u548c\u702c\u8cb4\u5f8b\u3001\u9ad8\u91ce\u6d0b\u5b50\u3001\u8352\u5ddd\u6d69\u4e00\u3001\u5927\u5cf6\u5b97\u5e73\u3001\u5c0f\u91ce\u6ca2\u3057\u306e\u3076\u3001\u5b87\u90fd\u6728\u654f\u6d69<br \/>\n\u5c0f\u51501\u578b\u7cd6\u5c3f\u75c5\u3078\u306e\u7c21\u6613\u578b\u8840\u7cd6\u8a8d\u8b58\u30c8\u30ec\u30fc\u30cb\u30f3\u30b0\u5c0e\u5165\u5f8c3\u5e74\u9593\u306e\u7d4c\u904e<\/p>\n<\/section>\n<section>\n<h4>\u7b2c64\u56de\u65e5\u672c\u30a2\u30ec\u30eb\u30ae\u30fc\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a\u30002015.5.27 \uff08\u6771\u4eac\uff09<\/h4>\n<p>\u539f\u3000\u5065\u4e00\u90ce\u3001\u9234\u6728\u96c5\u6587\u3001\u5c71\u53e3\u516c\u4e00\u3001\u5c71\u53e3\u3000\u5f69\u3001\u5897\u6e15\u88d5\u6717\u3001\u78ef\u90e8\u3000\u5168\u3001\u4e0a\u91ce\u5b66\u3001\u524d\u91ce\u654f\u5b5d\u3001Hirohito Kita,\u5009\u6797\u6b63\u5f66<br \/>\n\u9ec4\u8272\u30d6\u30c9\u30a6\u7403\u83cc\u306fIL-1\u03b1\u3092\u4ecb\u3057\u3066\u5438\u5165\u6297\u539f\u306b\u5bfe\u3059\u308b\u7279\u7570\u7684Th2\u578b\u514d\u75ab\u53cd\u5fdc\u3092\u4fc3\u9032\u3059\u308b<\/p>\n<\/section>\n<section>\n<h4>\u7b2c38\u56de\u65e5\u672c\u547c\u5438\u5668\u5185\u8996\u93e1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30002015.6.11-12\uff08\u6771\u4eac\uff09<\/h4>\n<p>1\uff09\u9234\u6728\u96c5\u6587\u3001\u539f\u3000\u5065\u4e00\u90ce\u3001\u5185\u7530\u3000\u6075\u3001\u5c71\u53e3\u3000\u5f69\u3001\u5c71\u53e3\u516c\u4e00\u3001\u5897\u6e15\u88d5\u6717\u3001\u9752\u6728\u3000\u671b\u3001\u9808\u8cc0\u9054\u592b\u3001\u524d\u91ce\u654f\u5b5d\u3001\u5009\u6797\u6b63\u5f66<br \/>\nSjogren\u75c7\u5019\u7fa4\u306b\u5408\u4f75\u3057\u305f\u6c17\u7ba1\u652f\u539f\u767aMALT\u30ea\u30f3\u30d1\u816b\u306e1\u4f8b<\/p>\n<p>2\uff09\u539f\u7530\u76f4\u4e4b\uff0c\u4e0a\u91ce\u3000\u5b66\uff0c\u4f50\u85e4\u9ebb\u91cc\uff0c\u76f8\u6fa4\u667a\u5f18\uff0c\u6298\u5c45\u7f8e\u6ce2\uff0c\u6e05\u6c34\u96c4\u81f3\uff0c\u8302\u6728\u3000\u5145<br \/>\n\u5f53\u9662\u306b\u304a\u3051\u308bEBUS-EBNA\u306e\u691c\u8a0e<\/p>\n<p>3\uff09\u9ad8\u91ce\u4fca\u4e00\uff0c\u4e0a\u91ce\u3000\u5b66\uff0c\u9234\u6728\u96c5\u6587\uff0c\u5897\u6e15\u88d5\u6717\uff0c\u539f\u5065\u4e00\u90ce\uff0c\u6298\u5c45\u7f8e\u6ce2\uff0c\u6e05\u6c34\u96c4\u81f3\uff0c\u8302\u6728\u3000\u5145<br \/>\n\u5f53\u9662\u306b\u304a\u3051\u308bAIDS\u5408\u4f75\u5b50\u547c\u5438\u5668\u611f\u67d3\u75c7\u60a3\u8005\u306b\u5bfe\u3059\u308b\u6c17\u7ba1\u652f\u93e1\u691c\u67fb\u306e\u6709\u7528\u6027 <\/p>\n<\/section>\n<section>\n<h4>\u7b2c615\u56de\u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u95a2\u6771\u5730\u65b9\u4f1a\u30002015.6.13\uff08\u6771\u4eac\uff09<\/h4>\n<p>\u963f\u90e8\u8cb4\u7d18\uff0c\u4e0a\u91ce\u3000\u5b66\uff0c\u539f\u7530\u76f4\u4e4b\uff0c\u4f50\u85e4\u9ebb\u91cc\uff0c\u6e05\u6c34\u96c4\u81f3\uff0c\u8302\u6728\u3000\u5145<br \/>\n\u9670\u830e\u3092\u542b\u3080\u9aa8\u76e4\u5185\u591a\u767a\u8ee2\u79fb\u3092\u6765\u3057\u305fEGFR\u907a\u4f1d\u5b50\u5909\u7570\u967d\u6027\u80ba\u817a\u764c\u306e1\u4f8b<\/p>\n<\/section>\n<section>\n<h4>American Society of Echocardiography2015\u30002015.6.12-16\uff08Boston\uff09<\/h4>\n<p>1\uff09Negishi T,Negishi K,Krassimira Hristova, Kurosawa K, Bogdan A. Popescu, Dragos Vinereanu,Paaladinesh Thavendiranathan, Goo-Yeong Cho, St\u00e9phanie Seldrum, Thomas H. Marwick<br \/>\nPrecision and Validity in the Strain Learning Curve: A Hill, Not a Mountain<\/p>\n<p>2\uff09Yoshida K,Obokata M,Negishi K,Kurosawa K,Sorimachi H,Kurabayashi M<br \/>\nSex Differences in Left Atrial Strain and its Relationship to CHADS2 Score in Patinets with Atrial Fibrillation<\/p>\n<p>3\uff09Kurosawa K,Negishi K,Sorimachi H,Yoshida K,ObokataM,Kurabayashi M.<br \/>\nNeither Left Atrial Appendage Emptying Flow Velocitynor Left Atrial Emptying Fraction, but Left Atrial Strainis Independently Associated with CHA2DS2-VASc Score<\/p>\n<\/section>\n<section>\n<h4>\u7b2c236\u56de\u65e5\u672c\u5faa\u74b0\u5668\u5b66\u4f1a\u95a2\u6771\u7532\u4fe1\u8d8a\u5730\u65b9\u4f1a\u30002015.6.20\uff08\u6771\u4eac\uff09<\/h4>\n<p>1\uff09\u62bc\u7530\u88d5\u559c\u3001\u5ca9\u6fa4\u5b5d\u660c\u3001\u6c34\u653f\u3000\u8c4a\u3001\u9ed2\u6728\u3000\u8302\u3001\u6749\u6d66\u3000\u5fb9\u3001\u6cca\u53e3\u54f2\u4e5f\u3001\u9577\u7530\u3000\u6df3<br \/>\n\u80ba\u80de\u51fa\u8840\u3068\u8a3a\u65ad\u3055\u308c\u3001\u624b\u8853\u307e\u30673\u9031\u9593\u3092\u8981\u3057\u305f\u6025\u6027\u50e7\u5e3d\u5f01\u9006\u6d41\u306e1\u4f8b<\/p>\n<p>2\uff09\u963f\u4e45\u6fa4\u66a2\u6d0b\u3001\u5927\u5c71\u5553\u592a\u3001\u9808\u8cc0\u4fca\u535a\u3001\u7fbd\u9ce5\u3000\u8cb4\u3001\u4eca\u4e95\u90a6\u5f66\u3001\u5317\u539f\u967d\u4e4b\u52a9<br \/>\n\u7279\u767a\u6027\u4e0a\u8178\u7ba1\u819c\u52d5\u8108\u89e3\u96e2\u3092\u5448\u3057\u305f3\u75c7\u4f8b\u306e\u81e8\u5e8a\u7684\u691c\u8a0e<\/p>\n<p>3\uff09\u83c5\u91ce\u5e78\u592a\u3001\u5c0f\u6797\u7d18\u751f\u3001\u5ca9\u702c\u6674\u9999\u3001\u5c0f\u6797\u6d0b\u660e\u3001\u67f3\u6fa4\u4e09\u6717\u3001\u798f\u7530\u5ef6\u662d\u3001\u9759\u3000\u6bc5\u4eba\u3001\u9f4b\u85e4\u7ae0\u5b8f\u3001\u5ee3\u4e95\u77e5\u6b73\u3001\u91d1\u6fa4\u7d00\u96c4<br \/>\n\u8a3a\u65ad\u306b\u82e6\u616e\u3057\u305f\u4e9c\u578b\u305f\u3053\u3064\u307c\u578b\u5fc3\u7b4b\u75c7\u306e\u4e00\u4f8b<\/p>\n<p>4\uff09\u83c5\u539f\u3000\u9686\u3001\u4e2d\u5cf6\u3000\u5fe0\u3001\u91d1\u53e4\u5584\u660e\u3001\u9577\u8c37\u5ddd\u3000\u5bdb\u3001\u98ef\u5cf6\u8cb4\u53f2\u3001\u592a\u7530\u660c\u6a39\u3001\u5009\u6797\u6b63\u5f66<br \/>\n\u5b8c\u5168\u623f\u5ba4\u30d6\u30ed\u30c3\u30af\u306b\u4f34\u3044torsades de pointes\u3092\u767a\u75c7\u3057\u305fKCNQ1-G269S\u5909\u7570\u30ad\u30e3\u30ea\u30a2<\/p>\n<p>5\uff09\u4e00\u8272\u96c4\u592a\u3001\u9577\u8c37\u5ddd\u3000\u5bdb\u3001\u5f8c\u85e4\u6176\u5927\u3001\u5c0f\u6c60\u6cf0\u5f18\u3001\u53cd\u753a\u79c0\u7f8e\u3001\u5897\u7530\u304f\u306b\u5b50\u3001\u4f50\u85e4\u4e07\u57fa\u4eba\u3001\u5c0f\u4fdd\u65b9\u3000\u512a\u3001\u677e\u5c3e\u5f25\u679d\u3001\u4f50\u91ce\u5b8f\u548c\u3001\u9ed2\u6ca2\u5e78\u55e3\u3001\u8239\u7530\u7adc\u4e00\u3001\u7b20\u9593\u3000\u5468\u3001\u9ad8\u9593\u5178\u660e\u3001\u5c0f\u677f\u6a4b\u7d00\u901a\u3001\u5009\u6797\u6b63\u5f66<br \/>\n\u30ea\u30aa\u30b7\u30b0\u30a2\u30c8\u304c\u594f\u529f\u3057\u305f\u9593\u8cea\u6027\u80ba\u708e\u3092\u5408\u4f75\u3057\u305f\u6162\u6027\u8840\u6813\u585e\u6813\u6027\u80ba\u9ad8\u8840\u5727\u75c7\u306e1\u4f8b<\/p>\n<p>6\uff09\u9808\u8cc0\u4fca\u535a\u3000\u5927\u5c71\u5553\u592a\u3000\u5965\u88d5\u5b50\u3000\u963f\u4e45\u6fa4\u66a2\u6d0b\u3000\u7fbd\u9ce5\u8cb4\u3000\u4eca\u4e95\u90a6\u5f66\u3000\u5317\u539f\u967d\u4e4b\u52a9<br \/>\n\u975e\u6897\u585e\u8cac\u4efb\u8840\u7ba1CTO\u306b\u5bfe\u3057\u3066\u9006\u884c\u6027\u30a2\u30d7\u30ed\u30fc\u30c1\u306b\u3088\u308b\u6bb5\u968e\u7684PCI\u3092\u884c\u3063\u305f\u30b7\u30e7\u30c3\u30af\u5408\u4f75AMI\u306e1\u4f8b<\/p>\n<\/section>\n<section>\n<h4>\u7b2c25\u56de\u65e5\u672c\u5fc3\u81d3\u6838\u533b\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u5927\u4f1a\u30002015.6.26-27\uff08\u6771\u4eac\uff09<\/h4>\n<p>\u7b20\u9593\u3000\u5468<br \/>\n\u5fc3\u81d3\u6838\u533b\u5b66\u3092\u7528\u3044\u305f\u5fc3\u4e0d\u5168\u8a55\u4fa1\uff08\u5fc3\u4e0d\u5168\u3078\u306e\u6838\u533b\u5b66\u7684\u30a2\u30d7\u30ed\u30fc\u30c1\uff09\u5fc3\u4e0d\u5168\u306e\u4e88\u5f8c\u4e88\u6e2c\u3000MIBG<\/p>\n<\/section>\n<section>\n<h4>TOPIC 2015 Tough &#038; Excellent Cases 2015.7.10\uff08\u6771\u4eac\uff09<\/h4>\n<p>\u9808\u8cc0\u4fca\u535a\u3000\u5927\u5c71\u5553\u592a\u3000\u5965\u88d5\u5b50\u3000\u963f\u4e45\u6fa4\u66a2\u6d0b\u3000\u7fbd\u9ce5\u8cb4\u3000\u4eca\u4e95\u90a6\u5f66\u3000\u5317\u539f\u967d\u4e4b\u52a9<br \/>\nSTEMI\u306b\u5bfe\u3057primary PCI\u5f8c\u3001\u6b8b\u5b58CTO\u306b\u5bfe\u3057\u3066staged retrograde approach PCI\u3092\u884c\u3063\u305f\u4e00\u4f8b<\/p>\n<\/section>\n<section>\n<h4>\u7b2c215\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u95a2\u6771\u5730\u65b9\u4f1a\u30002015.7.11\uff08\u6771\u4eac\uff09<\/h4>\n<p>\u6885\u6d25\u548c\u6075\u3001\u539f\u3000\u5065\u4e00\u90ce\u3001\u9808\u8cc0\u9054\u592b\u3001\u5927\u5cf6\u4e00\u771f\u3001\u5185\u7530\u3000\u6075\u3001\u9234\u6728\u96c5\u6587\u3001\u5c71\u53e3\u516c\u4e00\u3001\u5c71\u53e3\u3000\u5f69\u3001\u5897\u6e15\u88d5\u6717\u3001\u524d\u91ce\u654f\u5b5d<br \/>\n\u56a2\u80de\u5f62\u6210\u3092\u7d99\u6642\u7684\u306b\u8ffd\u3048\u305f\u826f\u6027\u8ee2\u79fb\u6027\u5e73\u6ed1\u7b4b\u816b\u306e\u4e00\u4f8b<\/p>\n<\/section>\n<section>\n<h4>\u7b2c21\u56de\u65e5\u672c\u5fc3\u81d3\u30ea\u30cf\u30d3\u30ea\u30c6\u30fc\u30b7\u30e7\u30f3\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30002015.7.19\uff08\u798f\u5ca1\uff09<\/h4>\n<p>\u9ad8\u9593\u5178\u660e<br \/>\nAdaptive servo-ventilation\u3092\u7528\u3044\u305f\u7761\u7720\u547c\u5438\u969c\u5bb3\u306a\u3089\u3073\u306b\u5fc3\u4e0d\u5168\u6cbb\u7642\u306e\u5b9f\u969b<\/p>\n<\/section>\n<section>\n<h4>\u7b2c616\u56de\u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u95a2\u6771\u5730\u65b9\u4f1a\u30002015.7.19\uff08\u6771\u4eac\uff09<\/h4>\n<p>\u4f50\u85e4\u4e07\u57fa\u4eba\uff0c\u8239\u7530\u7adc\u4e00\uff0c\u53cd\u753a\u79c0\u7f8e\uff0c\u4f50\u91ce\u5b8f\u548c\uff0c\u677e\u5c3e\u5f25\u679d\uff0c\u9ad8\u9593\u5178\u660e\uff0c\u7b20\u9593\u3000\u5468\uff0c\u5c0f\u677f\u6a4b\u7d00\u901a\uff0c\u5009\u6797\u6b63\u5f66<br \/>\n\u6025\u6027\u51a0\u75c7\u5019\u7fa4\u3092\u767a\u75c7\u3057\u305f\u30bf\u30f3\u30b8\u30fc\u30eb\u75c5\u306e1\u75c7\u4f8b<\/p>\n<\/section>\n<section>\n<h4>\u7b2c30\u56de\u65e5\u672c\u4e0d\u6574\u8108\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a\u30002015.7.28-31\uff08\u4eac\u90fd\uff09<\/h4>\n<p>1\uff09\u677e\u5c3e\u5f25\u679d<br \/>\nLeft atrial appendage closure for stroke prevention-reports from European high volume center<\/p>\n<p>2\uff09\u677e\u5c3e\u5f25\u679d<br \/>\nFeasibility of Temporary Figure of Eight subcutaneous Suture after Femoral Vein Puncture<\/p>\n<p>3\uff09\u677e\u5c3e\u5f25\u679d<br \/>\nLeft Atrial Appendage Closure with Intracardiac echo guidance<\/p>\n<p>4\uff09Ota M,Kaneko Y,Nakajima T,Irie T,Iijima T,Kurabayashi M<br \/>\nFactors Underlying the Development of Perimitral Atrial Flutter after Extensive Encircling Pulmonary Vein Isolation. <\/p>\n<p>5\uff09Kaneko Y,Nakajima T,Ota M,Iijima T,Kurabayashi M.<br \/>\nPutative mechanism of a transient prolongation of AH interval during fast-slow atrioventricular nodal reentrant tachycardia. <\/p>\n<p>6\uff09Nakajima T,Kaneko Y,Saito A,Ota M,Iijima T,Kurabayashi M.<br \/>\nEnhanced fast-inactivated state stability of cardiac sodium channels by a novel voltage sensor SCN5A mutation R1632C as a cause of multiple electrophysiological phenotypes<\/p>\n<p>7\uff09Ota\u3000M, Kaneko Y, Nakajima T, Irie T, Iijima T, Kurabayashi M<br \/>\nFactors Underlying the Development of Perimitral Atrial Flutter after Extensive Encircling Pulmonary Vein Isolation. <\/p>\n<\/section>\n<section>\n<h4>\u7b2c24\u56de\u65e5\u672c\u5fc3\u8840\u7ba1\u30a4\u30f3\u30bf\u30fc\u30d9\u30f3\u30b7\u30e7\u30f3\u6cbb\u7642\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff08CVIT2015\uff09\u30002015.7.30-8.1\uff08\u798f\u5ca1\uff09<\/h4>\n<p>1\uff09\u677e\u5c3e\u5f25\u679d\u3001\u8239\u7530\u3000\u7adc\u4e00\u3001\u6238\u7530\u3000\u548c\u8fb0\u3001\u5e02\u5ddd\u3000\u5553\u4ecb\u3001\u53cd\u753a\u3000\u79c0\u7f8e\u3001\u5c0f\u4fdd\u65b9\u512a\u3001\u4f50\u85e4\u4e07\u57fa\u4eba\u3001\u4f50\u91ce\u3000\u5b8f\u548c\u3001\u7b20\u9593\u3000\u3000\u5468\u3001\u9ad8\u9593\u3000\u5178\u660e\u3001\u5c0f\u677f\u6a4b\u7d00\u901a\u3001\u5009\u6797\u3000\u6b63\u5f66<br \/>\nChallenging case of transradial Rotablator ablation succeeded by the Guide Liner V2 catheter<\/p>\n<p>2\uff09\u677e\u5c3e\u5f25\u679d\u3001\u8239\u7530\u3000\u7adc\u4e00\u3001\u6238\u7530\u3000\u548c\u8fb0\u3001\u5e02\u5ddd\u3000\u5553\u4ecb\u3001\u53cd\u753a\u3000\u79c0\u7f8e\u3001\u5c0f\u4fdd\u65b9\u512a\u3001\u4f50\u85e4\u4e07\u57fa\u4eba\u3001\u4f50\u91ce\u3000\u5b8f\u548c\u3001\u7b20\u9593\u3000\u3000\u5468\u3001\u9ad8\u9593\u3000\u5178\u660e\u3001\u5c0f\u677f\u6a4b\u7d00\u901a\u3001\u5009\u6797\u3000\u6b63\u5f66<br \/>\nChronic thromboembolic pulmonary hypertension case with successful balloon pulmonary angioplasty in a critical condition<\/p>\n<p>3\uff09\u677e\u5c3e\u5f25\u679d\u3001\u8239\u7530\u3000\u7adc\u4e00\u3001\u6238\u7530\u3000\u548c\u8fb0\u3001\u5e02\u5ddd\u3000\u5553\u4ecb\u3001\u53cd\u753a\u3000\u79c0\u7f8e\u3001\u5c0f\u4fdd\u65b9\u512a\u3001\u4f50\u85e4\u4e07\u57fa\u4eba\u3001\u4f50\u91ce\u3000\u5b8f\u548c\u3001\u7b20\u9593\u3000\u3000\u5468\u3001\u9ad8\u9593\u3000\u5178\u660e\u3001\u5c0f\u677f\u6a4b\u7d00\u901a\u3001\u5009\u6797\u3000\u6b63\u5f66<br \/>\nFeasibility of temporary figure of eight subcutaneous suture after femoral vein puncture<\/p>\n<p>4\uff09\u4f50\u85e4\u4e07\u57fa\u4eba\u3001\u8239\u7530\u3000\u7adc\u4e00\u3001\u6238\u7530\u3000\u548c\u8fb0\u3001\u5e02\u5ddd\u3000\u5553\u4ecb\u3001\u53cd\u753a\u3000\u79c0\u7f8e\u3001\u5c0f\u4fdd\u65b9\u512a\u3001\u677e\u5c3e\u3000\u5f25\u679d\u3001\u4f50\u91ce\u3000\u5b8f\u548c\u3001\u7b20\u9593\u3000\u3000\u5468\u3001\u9ad8\u9593\u3000\u5178\u660e\u3001\u5c0f\u677f\u6a4b\u7d00\u901a\u3001\u5009\u6797\u3000\u6b63\u5f66<br \/>\nBelow Knee Intervention for a Patient with Systemic Critical Limb Ischemia<\/p>\n<p>\u6b27\u5dde\u5fc3\u81d3\u75c5\u5b66\u4f1a\uff08ESC\uff092015\u30002015.8.29-9.2\uff08London\uff09<\/h4>\n<p>1\uff09Matsuo Y.<br \/>\nLearning curve of percutaneous left atrial appendage closure for stroke prevention in single high volume center<\/p>\n<p>2\uff09Matsuo Y.<br \/>\nLong term result of the left atrial appendage closure for stroke prevention in single high volume center<\/p>\n<p>3\uff09Nakajima T,Kaneko Y,Saito A,Ota M,Iijima T,Kurabayashi M<br \/>\nEnhanced fast-inactivated state stability of cardiac sodium channels by a novel voltage multiple electrophysiological phenotypes<\/p>\n<p>4\uff09Goto K,Takama N,Hasegawa H,Koike Y,Masuda K,Sorimachi H,Sato M,Obotaka M,Matsuo Y,Sano H,Funada R,Kasama S,Koitabashi N,Kurabayashi M<br \/>\nA Long-Term Prognosis of Adaptive Servo ventilation Therapy for Patients with Heart Failure Regardless of the Severity of Sleep-Disordered Breathing.<\/p>\n<p>5\uff09Obokata M<br \/>\nTreserved ventricular-arterial coupling but more myocardial oxygen consumption and less mechanical efficiency in haemodialysis patients.<\/p>\n<p>6\uff09Kato T<br \/>\nImpact of adaptive servo ventilation therapy on cardiovascular event free survial in feart failure patients.<\/p>\n<\/section>\n<section>\n<h4>\u7b2c63\u56de\u65e5\u672c\u5fc3\u81d3\u75c5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30002015\uff0e9.15\uff0d20\uff08\u6a2a\u6d5c\uff09<\/h4>\n<p>1\uff09\u98ef\u5cf6\u8cb4\u53f2\u3001\u91d1\u53e4\u5584\u660e\u3001\u4e2d\u5cf6\u3000\u5fe0\u3001\u5009\u6797\u6b63\u5f66\u3001\u5165\u6c5f\u5fe0\u4fe1\u3001\u658e\u85e4\u7ae0\u5b8f\u3001\u7530\u6751\u672a\u592e\u3001\u98ef\u585a\u8cb4\u58eb\u3001\u7530\u6751 \u5cfb\u592a\u90ceFDG\u306e\u5fc3\u623f\u7b4b\u3078\u96c6\u7a4d\u3059\u308b\u75c5\u614b\u306b\u3064\u3044\u3066\u306e\u691c\u8a0e <\/p>\n<p>2\uff09\u7530\u6751\u5cfb\u592a\u90ce\u3001\u91d1\u53e4\u5584\u660e\u3001\u4e2d\u5cf6\u3000\u5fe0\u3001\u592a\u7530\u660c\u6a39\u3001\u98ef\u5cf6\u8cb4\u53f2\u3001\u78ef\u3000\u9054\u4e5f\u3001\u5009\u6797\u6b63\u5f66<br \/>\n\u8102\u80aa\u9178\u7d50\u5408\u30bf\u30f3\u30d1\u30af\u8ceaFABP4\u306f\u52d5\u8108\u7cfb\u306b\u5206\u6ccc\u3055\u308c\u308b\uff1a\u5faa\u74b0\u52d5\u614b\u30de\u30fc\u30ab\u30fc\u3068\u3057\u3066\u306e\u53ef\u80fd\u6027\uff0e <\/p>\n<p>3\uff09\u677e\u5d0e\u667a\u5b50\u3001\u9ad8\u9593\u5178\u660e\u3001\u5c0f\u4fdd\u65b9\u3000\u512a\u3001\u5009\u6797\u6b63\u5f66<br \/>\nFABP4\u306e\u7d4c\u6642\u7684\u89b3\u5bdf\u304c\u53ef\u80fd\u3067\u3042\u3063\u305f\u5287\u75c7\u578b\u5fc3\u7b4b\u708e\u306e\u4e00\u4f8b<\/p>\n<p>4\uff09\u9ad8\u9593\u5178\u660e\u3001\u5009\u6797\u6b63\u5f66<br \/>\n\u5faa\u74b0\u5668\u75be\u60a3\u306b\u304a\u3051\u308b\u7761\u7720\u547c\u5438\u969c\u5bb3\u306e\u91cd\u8981\u6027\u2015Real World\u3067\u306e\u691c\u8a0e\u2015<\/p>\n<p>5\uff09\u5916\u5c71\u5353\u4e8c\u3001\u7b20\u9593\u3000\u5468\u3001\u4e2d\u539f\u5065\u88d5\u3001\u4e0a\u7530\u54f2\u4e5f\u3001\u4f50\u3005\u6728\u8c4a\u5fd7\u3001\u5c71\u5cb8\u9ad8\u5e83\u3001\u5009\u6797\u6b63\u5f66<br \/>\n\u6162\u6027\u814e\u81d3\u75c5\u60a3\u8005\u306b\u304a\u3051\u308b\u4e3b\u8981\u5fc3\u8840\u7ba1\u30a4\u30d9\u30f3\u30c8\u4e88\u6e2c\u306b\u5bfe\u3059\u308b\u8ca0\u8377\u5fc3\u7b4b\u8840\u6d41SPECT\u306e\u6709\u7528\u6027\u2015\u7fa4\u99acCKD\u591a\u65bd\u8a2d\u5171\u540c\u7814\u7a76\u306e\u7d50\u679c\u304b\u3089\u30fc<\/p>\n<p>6\uff09\u6238\u7530\u548c\u8fb0\u3001\u7b20\u9593\u3000\u5468\u3001\u5e02\u5ddd\u5553\u4ecb\u3001\u53cd\u753a\u79c0\u7f8e\u3001\u5409\u7530\u304f\u306b\u5b50\u3001\u4f50\u85e4\u4e07\u57fa\u4eba\u3001\u5c0f\u4fdd\u65b9\u3000\u512a\u3001\u677e\u5c3e\u5f25\u679d\u3001\u4f50\u91ce\u5b8f\u548c\u3001\u9ed2\u6ca2\u5e78\u55e3\u3001\u8239\u7530\u7adc\u4e00\u3001\u9ad8\u9593\u5178\u660e\u3001\u5c0f\u677f\u6a4b\u7d00\u901a\u3001\u5009\u6797\u6b63\u5f66<br \/>\n\u6162\u6027\u5fc3\u4e0d\u5168\u306b\u304a\u3051\u308b\u9ad8\u5bb9\u91cf\u306e\u03b2\u906e\u65ad\u85ac\u6cbb\u7642\u306f\u6a19\u6e96\u5bb9\u91cf\u6cbb\u7642\u3068\u6bd4\u8f03\u3057\u5fc3\u81d3\u4ea4\u611f\u795e\u7d4c\u6d3b\u6027\u3092\u3088\u308a\u6539\u5584\u3067\u304d\u308b\u306e\u304b\uff1f<\/p>\n<p>7\uff09\u5e02\u5ddd\u5553\u4ecb\u3001\u7b20\u9593\u3000\u5468\u3001\u6238\u7530\u548c\u8fb0\u3001\u53cd\u753a\u79c0\u7f8e\u3001\u5409\u7530\u304f\u306b\u5b50\u3001\u4f50\u85e4\u4e07\u57fa\u4eba\u3001\u5c0f\u4fdd\u65b9\u3000\u512a\u3001\u677e\u5c3e\u5f25\u679d\u3001\u4f50\u91ce\u5b8f\u548c\u3001\u9ed2\u6ca2\u5e78\u55e3\u3001\u8239\u7530\u7adc\u4e00\u3001\u9ad8\u9593\u5178\u660e\u3001\u5c0f\u677f\u6a4b\u7d00\u901a\u3001\u5009\u6797\u6b63\u5f66<br \/>\n\u6162\u6027\u5fc3\u4e0d\u5168\u75c7\u4f8b\u306b\u5bfe\u3059\u308b\u9577\u6642\u9593\u4f5c\u7528\u578b\u30eb\u30fc\u30d7\u5229\u5c3f\u85ac\u3068\u77ed\u6642\u9593\u4f5c\u7528\u578b\u30eb\u30fc\u30d7\u5229\u5c3f\u85ac\u306e\u5fc3\u81d3\u4ea4\u611f\u795e\u7d4c\u6d3b\u6027\u306b\u53ca\u307c\u3059\u52b9\u679c\u306e\u6bd4\u8f03\u691c\u8a0e<\/p>\n<p>8\uff09\u53cd\u753a\u79c0\u7f8e\u3001\u6839\u5cb8\u548c\u660e\u3001\u9ed2\u6ca2\u5e78\u55e3\u3001\u5c0f\u4fdd\u65b9\u3000\u512a\u3001\u5409\u7530\u304f\u306b\u5b50\u3001\u4e39\u4e0b\u6b63\u4e00\u3001\u5009\u6797\u6b63\u5f66<br \/>\n\u5fc3\u7b4b\u8cea\u91cf\u4fc2\u6570\u306e\u5897\u52a0\u306f\u7537\u6027\u3088\u308a\u3082\u5973\u6027\u306e\u65b9\u304c\u3088\u308a\u5de6\u5ba4\u5f1b\u7de9\u80fd\u3092\u4f4e\u4e0b\u3055\u305b\u308b<\/p>\n<\/section>\n<section>\n<h4>\u7b2c617\u56de\u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u95a2\u6771\u5730\u65b9\u4f1a\u30002015.9.12\uff08\u6771\u4eac\uff09<\/h4>\n<p>\u5f97\u5c45\u4fca\u4ecb\uff0c\u9ad8\u91ce\u5cfb\u4e00\uff0c\u795e\u6238\u5c06\u5f66\uff0c\u6c60\u7530\u9999\u83dc\uff0c\u4e2d\u5ddd\u7d14\u4e00\uff0c\u585a\u8d8a\u6b63\u7ae0<br \/>\n\u5927\u8178\u304c\u3093\u306b\u5bfe\u3057\u3066\u5316\u5b66\u7642\u6cd5\u4e2d\u306b\u30cb\u30e5\u30fc\u30e2\u30b7\u30b9\u30c1\u30b9\u80ba\u708e\uff08PCP\uff09\u3068\u30b5\u30a4\u30c8\u30e1\u30ac\u30ed\u30a6\u30a4\u30eb\u30b9\uff08CMV\uff09\u80ba\u708e\u3092\u4f75\u767a\u3057\u305f1\u4f8b<\/p>\n<\/section>\n<section>\n<h4>\u7b2c168\u56de\u65e5\u672c\u7d50\u6838\u75c5\u5b66\u95a2\u6771\u652f\u90e8\u5b66\u4f1a\u7b2c216\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u95a2\u6771\u5730\u65b9\u4f1a\u5408\u540c\u5b66\u4f1a\u30002015.9.26\uff08\u524d\u6a4b\uff09<\/h4>\n<p>\u795e\u6238\u5c06\u5f66\u3001\u4e2d\u5ddd\u7d14\u4e00\u3001\u9ad8\u91ce\u5cfb\u4e00\u3001\u6c60\u7530\u9999\u83dc\u3001\u585a\u8d8a\u6b63\u7ae0\u3001\u9808\u8cc0\u9054\u592b\u3001\u8302\u6728\u3000\u5145\u3001\u524d\u91ce\u654f\u5b5d<br \/>\n\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u6cbb\u7642\u4e2d\u306b\u591a\u767a\u6d78\u6f64\u5f71\u3092\u5448\u3057\u6025\u6027\u547c\u5438\u4e0d\u5168\u306b\u81f3\u3063\u305f\u7d9a\u767a\u6027\u80ba\u30af\u30ea\u30d7\u30c8\u30b3\u30c3\u30ab\u30b9\u75c7\u306e\u4e00\u4f8b<\/p>\n<\/section>\n<section>\n<h4>\u7b2c19\u56de\u65e5\u672c\u6813\u5b50\u691c\u51fa\u3068\u6cbb\u7642\u5b66\u4f1a\u30002015.9.25-26\uff08\u5b87\u90fd\u5bae\uff09<\/h4>\n<p>\u677e\u5c3e\u5f25\u679d<br \/>\n\u5de6\u5fc3\u8033\u9589\u9396\u8853\u306b\u3088\u308b\u585e\u6813\u75c7\u4e88\u9632<\/p>\n<\/section>\n<section>\n<h4>\u7b2c237\u56de\u65e5\u672c\u5faa\u74b0\u5668\u5b66\u4f1a\u95a2\u6771\u7532\u4fe1\u8d8a\u5730\u65b9\u4f1a\u30002015.9.26\uff08\u6771\u4eac\uff09<\/h4>\n<p>1\uff09\u5f8c\u85e4\u6176\u5927\u3001\u4f50\u85e4\u4e07\u57fa\u4eba\u3001\u5c0f\u6c60\u6cf0\u5f18\u3001\u53cd\u753a\u79c0\u7f8e\u3001\u677e\u5c3e\u5f25\u679d\u3001\u4f50\u91ce\u5b8f\u548c\u3001\u8239\u7530\u7adc\u4e00\u3001\u9ad8\u9593\u5178\u660e\u3001\u7b20\u9593\u3000\u5468\u3001\u5009\u6797\u6b63\u5f66<br \/>\n\u5fc3\u80ba\u505c\u6b62\u3068\u306a\u308a\u8607\u751f\u3057\u305fKounis\u75c7\u5019\u7fa4\u3092\u5fc3\u7b4b\u30b7\u30f3\u30c1\u30b0\u30e9\u30d5\u30a3\u3067\u8a55\u4fa1\u3057\u3048\u305f\u4e00\u4f8b<\/p>\n<p>2\uff09\u6751\u7530\u3000\u8aa0\u3001\u5b89\u9054\u3000\u4ec1\u3001\u5bae\u77f3\u88d5\u4ecb\u3001\u7c21\u3000\u4f2f\u61b2\u3001\u5c71\u4e0b\u82f1\u6cbb\u3001\u6cb3\u53e3\u3000\u5ec9\u3001\u661f\u5d0e\u3000\u6d0b\u3001\u5927\u5cf6\u3000\u8302\u3001\u6850\u8c37\u3086\u308a\u5b50\u3001\u5c0f\u524d\u5175\u885b\u3001\u5c0f\u6b64\u6728\u4fee\u4e00\u3001\u5ca1\u7530\u4fee\u4e00\u3001\u6728\u6751\u77e5\u6075\u7406\u3001\u9577\u8c37\u5ddd\u8c4a\u3001\u6c5f\u9023\u96c5\u5f66\u3001\u91d1\u5b50\u9054\u592b<br \/>\nTAVR\u5f8c\u306b\u904b\u52d5\u5fc3\u80ba\u8ca0\u8377\u8a66\u9a13\u3092\u65bd\u884c\u3057\u3001\u904b\u52d5\u8010\u5bb9\u80fd\u6539\u5584\u3092\u8a8d\u3081\u305f\u4e00\u4f8b<\/p>\n<\/section>\n<section>\n<h4>\u7b2c216\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u95a2\u6771\u5730\u65b9\u4f1a\u30002015.9.26\uff08\u524d\u6a4b\uff09<\/h4>\n<p>1\uff09\u672c\u5e84\u7d14\u4e00\u90ce\u3001\u5c71\u53e3\u516c\u4e00\u3001\u5c71\u53e3\u5f69\u3000\u5897\u6e15\u88d5\u6717\u3001\u9234\u6728\u96c5\u6587\u3001\u5185\u7530\u3000\u6075\u3001\u6885\u6d25\u548c\u6075\u5927\u5cf6\u4e00\u771f\u3001\u539f\u3000\u5065\u4e00\u90ce\u3001\u9808\u8cc0\u9054\u592b\u3001\u524d\u91ce\u654f\u5b5d\u3001\u4e45\u7530\u525b\u5fd7<br \/>\n\u843d\u8449\u72b6\u5929\u75b1\u7621\u306e\u8a3a\u65ad\u6642\u306b\u540c\u6642\u306b\u767a\u898b\u3055\u308c\u305f\u80ba\u5c0f\u7d30\u80de\u764c\u306e\u4e00\u4f8b<\/p>\n<p>2\uff09\u4f50\u85e4\u9ebb\u91cc\u3001\u8302\u6728\u5145\u3001\u539f\u7530\u76f4\u4e4b\u3001\u4e0a\u91ce\u3000\u5b66\u3001\u6e05\u6c34\u96c4\u81f3<br \/>\n\u6025\u901f\u306b\u80ba\u9ad8\u8840\u5727\u304c\u9032\u884c\u3057Pulmonary tumor thrombotic microangiopathy\u304c\u7591\u308f\u308c\u305f\u80ba\u6241\u5e73\u4e0a\u76ae\u764c\u306e1\u4f8b<\/p>\n<\/section>\n<section>\n<h4>\u7b2c4\u56de\u80ba\u5faa\u74b0\u5b66\u4f1a\u7dcf\u4f1a\u30002015.10.3\uff08\u6771\u4eac\uff09<\/h4>\n<p>\u53cd\u753a\u79c0\u7f8e<br \/>\n\u5f53\u9662\u306b\u304a\u3051\u308b\u80ba\u9ad8\u8840\u5727\u75c7\u306b\u5bfe\u3059\u308b\u30ea\u30aa\u30b7\u30b0\u30a2\u30c8\u306e\u4f7f\u7528\u7d4c\u9a13<\/p>\n<\/section>\n<section>\n<h4>\u7b2c22\u56de\u65e5\u672c\u672a\u75c5\u30b7\u30b9\u30c6\u30e0\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\u30002015.10.10-12\uff08\u672d\u5e4c\uff09<\/h4>\n<p>\u9808\u6c38\u6d69\u7ae0\u3001\u78ef\u3000\u9054\u4e5f\u3001\u5927\u5c71\u5584\u662d\u3001\u5c0f\u4fdd\u65b9\u3000\u512a\u3001\u6cb3\u53e3\u667a\u9999\u3001\u5c0f\u677f\u6a4b\u3000\u7d00\u901a\u3001Mas Rizky A.A Syamsunarno\u3001\u677e\u4e95\u5f18\u6a39\u3001\u6a2a\u5c71\u77e5\u884c\u3001\u5009\u6797\u6b63\u5f66<br \/>\n\u8102\u80aa\u9178\u7d50\u5408\u30bf\u30f3\u30d1\u30afFABP4\u306f\u6025\u6027\u5fc3\u7b4b\u6897\u585e\u306e\u65e9\u671f\u8a3a\u65ad\u30de\u30fc\u30ab\u30fc\u3068\u3057\u3066\u6709\u7528\u3067\u3042\u308b<\/p>\n<\/section>\n<section>\n<h4>\u7b2c25\u56de\u65e5\u672c\u547c\u5438\u30b1\u30a2\u30fb\u30ea\u30cf\u30d3\u30ea\u30c6\u30fc\u30b7\u30e7\u30f3\u5b66\u4f1a\u30002015.10.15\uff08\u5343\u8449\uff09<\/h4>\n<p>\u5185\u7530\u3000\u6075\u3001\u9234\u6728\u96c5\u6587\u3001\u5c71\u53e3\u516c\u4e00\u3001\u5c71\u53e3\u3000\u5f69\u3001\u5897\u6e15\u88d5\u6717\u3001\u539f\u5065\u4e00\u90ce\u3001\u9752\u6728\u3000\u671b\u3001\u524d\u91ce\u654f\u5b5d\u3001\u9808\u8cc0\u9054\u592b\u3001\u5009\u6797\u6b63\u5f66<br \/>\n\u5faa\u74b0\u5668\u75be\u60a3\u3092\u5408\u4f75\u3057\u305fCOPD\u60a3\u8005\u306e\u6cbb\u7642\u306b\u95a2\u3059\u308b\u691c\u8a0e<\/p>\n<\/section>\n<section>\n<h4>\u7b2c19\u56de\u65e5\u672c\u5fc3\u4e0d\u5168\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30002015.10.22-24\uff08\u5927\u962a\uff09<\/h4>\n<p>1\uff09Koitabashi N,Yamamoto M,Musashi T,Samejima M,Iso T,Imamura H,Kurabayashi M.<br \/>\n\u751f\u4f53\u5185ATP\u53ef\u8996\u5316\u30e2\u30c7\u30eb\u3067\u5fc3\u81d3\u30a8\u30ca\u30b8\u30a7\u30c6\u30a3\u30af\u30b9\u3092\u518d\u8a55\u4fa1\u3059\u308b<\/p>\n<p>2\uff09Umeyama\u3000A,Takama\u3000N,Goto\u3000K,Nakajima\u3000M,Higuchi\u3000K,Yamagishi\u3000T,Kurabayashi\u3000M<br \/>\nLow Integrated Area of Desaturation Index after ASV Therapy is Strong Indicator to Predict Cardiovascular Events in Heart Failure Patients<\/p>\n<\/section>\n<section>\n<h4>\u7b2c61\u56de\u7fa4\u99ac\u770c\u533b\u5b66\u691c\u67fb\u5b66\u4f1a\u30002015.10.25\uff08\u524d\u6a4b\uff09<\/h4>\n<p>\u68ee\u7530\u572d\u5b50\u3001\u5ca1\u7530\u9855\u4e5f\u3001\u9ed2\u6ca2\u5e78\u55e3\u3001\u751f\u99d2\u5353\u5b8f\u3001\u4e39\u6ce2\u52a0\u5948\u5b50\u3001\u9ad8\u7530\u667a\u5b50\u3001\u753a\u7530\u54f2\u7537\u3001\u6751\u4e0a\u6b63\u5df3<br \/>\n\u53f3\u623f\u7c98\u6db2\u816b\u306e\u4e00\u4f8b<\/p>\n<\/section>\n<section>\n<h4>\u9928\u6797\u9091\u697d\u5730\u533a\u533b\u5e2b\u4f1a\u5b66\u8853\u96c6\u4f1a\u30002015.10.29\uff08\u9928\u6797\uff09<\/h4>\n<p>\u9ad8\u9593\u5178\u660e<br \/>\n\u8840\u6813\u6027\u75be\u60a3\u306eUp to date<\/p>\n<\/section>\n<section>\n<h4>\u7b2c16\u56de\u65e5\u672c\u30af\u30ea\u30cb\u30ab\u30eb\u30d1\u30b9\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u3000\u30b7\u30f3\u30dd\u30b8\u30a6\u30e03\u3000\u6804\u990a\u7ba1\u7406\u3068\u5730\u57df\u9023\u643a\u2014\u75c5\u9662\u304b\u3089\u5730\u57df\u3078\u30fc\u30002015.11.13\uff08\u821e\u6d5c\uff09<\/h4>\n<p>\u6e05\u6c34\u96c4\u81f3\u3000<br \/>\n\u6804\u990a\u7642\u6cd5\u3092\u91cd\u8996\u3057\u305fCOPD\u5730\u57df\u9023\u643a\u30d1\u30b9\u306e\u5c0e\u5165<\/p>\n<\/section>\n<section>\n<h4>\u7b2c619\u56de\u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u95a2\u6771\u5730\u65b9\u4f1a2015.11.14\uff08\u6771\u4eac\uff09<\/h4>\n<p>1\uff09\u83ca\u6c60\u96c4\u592a\u90ce\u3001\u592a\u7530\u660c\u6a39\u3001\u98ef\u585a\u8cb4\u58eb\u3001\u98ef\u5cf6\u8cb4\u53f2\u3001\u4e2d\u5cf6\u3000\u5fe0\u3001\u91d1\u53e4\u5584\u660e\u3001\u5009\u6797\u6b63\u5f66<br \/>\n\u5fc3\u5ba4\u7d30\u52d5\u8607\u751f\u5f8c\u306eBrugada\u75c7\u5019\u7fa4\u306b\u51a0\u6523\u7e2e\u6027\u72ed\u5fc3\u75c7\u306e\u4f75\u767a\u304c\u7591\u308f\u308c\u305f1\u4f8b\uff0e<\/p>\n<p>2\uff09\u98ef\u585a\u7d17\u5e0c\uff0c\u539f\u3000\u5065\u4e00\u90ce\u3001\u5185\u7530\u3000\u6075\u3001\u6885\u6d25\u548c\u6075\u3001\u5927\u5cf6\u4e00\u771f\u3001\u9234\u6728\u96c5\u6587\u3001\u5c71\u53e3\u516c\u4e00\u3001\u5897\u6e15\u88d5\u6717\u3001\u524d\u91ce\u654f\u5b5d\u3001\u4e45\u7530\u525b\u5fd7<br \/>\n\u597d\u9178\u7403\u6027\u591a\u767a\u8840\u7ba1\u708e\u6027\u8089\u82bd\u816b\u75c7\u306e\u6cbb\u7642\u7d4c\u904e\u4e2d\u306b\u80a5\u539a\u6027\u786c\u819c\u708e\u3092\u5408\u4f75\u3057\u305f\u4e00\u4f8b<\/p>\n<\/section>\n<section>\n<h4>\u7b2c62\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff08\u5c90\u961c\uff09<\/h4>\n<p>\u9ed2\u6ca2\u5e78\u55e3\u3001\u89d2\u91ce\u535a\u4e4b\u3001\u9ad8\u7530\u667a\u5b50\u3001\u5ca1\u7530\u9855\u4e5f\u3001\u753a\u7530\u54f2\u592b\u3001\u5009\u6797\u6b63\u5f66\u3001\u6751\u4e0a\u6b63\u5df3<br \/>\n\u5973\u6027\u60a3\u8005\u306e\u7d4c\u80f8\u58c1\u5fc3\u30a8\u30b3\u30fc\u56f3\u691c\u67fb\u65bd\u884c\u306b\u304a\u3051\u308b\u691c\u8005\u6027\u5225\u5e0c\u671b\u306b\u95a2\u3059\u308b\u691c\u8a0e<\/p>\n<\/section>\n<section>\n<h4>Asian Pacific Heart Rhythm Society Scientific Sessions (APHRS 2015\uff09\u30002015.11.21\uff08Melbourne \uff09<\/h4>\n<p>1\uff09Kaneko Y, Naito S, Okishige K, Morishima I, Tobiume T, Nakajima T, Irie T, Kato R, Matsumoto K, Suzuki F, Kurabayashi M<br \/>\nAtypical fast-slow atrioventricular nodal reentrant tachycardia incorporating a \u201csuperior\u201d slow pathway: a distinct supraventricular tachyarrhythmia.<\/p>\n<p>2\uff09Iijima\u3000T,Kaneko\u3000Y,Nakajima\u3000T,Irie\u3000T,Ota\u3000M,Tamura\u3000M,Iizuka\u3000T,Tamura\u3000S,Saito A,Kurabayashi M<br \/>\nA case of atrioventricular nodal reentrant tachycardia with the earliest atrial activation atposterolateral right atrium.<\/p>\n<\/section>\n<section>\n<h4>\u7b2c217\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u95a2\u6771\u5730\u65b9\u4f1a\u30002015.11.21 \uff08\u6771\u4eac\uff09<\/h4>\n<p>\u91d1\u8c37\u79c0\u5e73\u3001\u5c71\u53e3\u516c\u4e00\u3001\u5c71\u53e3\u3000\u5f69\u3001\u9234\u6728\u96c5\u6587\u3001\u5185\u7530\u3000\u6075\u3001\u6885\u6d25\u548c\u6075\u3001\u5927\u5cf6\u4e00\u771f\u3001\u5897\u6e15\u88d5\u6717\u3001\u539f\u3000\u5065\u4e00\u90ce\u3001\u9808\u8cc0\u9054\u592b\u3001\u524d\u91ce\u654f\u5b5d\u3001\u4e45\u7530\u525b\u5fd7<br \/>\n\u9855\u5fae\u93e1\u7684\u591a\u767a\u8840\u7ba1\u708e\u306e\u6cbb\u7642\u4e2d\u306b\u767a\u75c7\u3057\u305f\u30ea\u30dd\u30a4\u30c9\u80ba\u708e\u306e\u4e00\u4f8b<\/p>\n<\/section>\n<section>\n<h4>\u7b2c56\u56de\u65e5\u672c\u80ba\u764c\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a2015.11.26-28\uff08\u6a2a\u6d5c\uff09<\/h4>\n<p>\u5927\u5cf6\u4e00\u771f\u3001\u539f\u3000\u5065\u4e00\u90ce\u3001\u5897\u6e15\u88d5\u6717\u3001\u6885\u6d25\u548c\u6075\u3001\u5185\u7530\u6075\u3001\u9234\u6728\u96c5\u6587\u3001\u5c71\u53e3\u516c\u4e00\u5c71\u53e3\u3000\u5f69\u3001\u9808\u8cc0\u9054\u592b\u3001\u524d\u91ce\u654f\u5b5d\u3001\u4e45\u7530\u525b\u5fd7\u3001\u5317\u539f\u4fe1\u4ecb<br \/>\n\u518d\u767a\u8ee2\u79fb\u75c5\u5909\u306b\u5bfe\u3059\u308b\u5c40\u6240\u5236\u5fa1\u3092\u7e70\u308a\u8fd4\u3057\u9577\u671f\u9593\u306e\u75c5\u52e2\u30b3\u30f3\u30c8\u30ed\u30fc\u30eb\u304c\u53ef\u80fd\u3067\u3042\u3063\u305f\u80ba\u5c0f\u7d30\u80de\u764c\u306e\u4e00\u4f8b<\/p>\n<\/section>\n<section>\n<h4>\u7b2c238\u56de\u65e5\u672c\u5faa\u74b0\u5668\u5b66\u4f1a\u95a2\u6771\u7532\u4fe1\u8d8a\u5730\u65b9\u4f1a\u30002015.12.5\u3000\uff08\u6771\u4eac\uff09<\/h4>\n<p>\u62bc\u7530\u88d5\u559c\u3001\u9577\u7530\u3000\u6df3\u3001\u6cca\u53e3\u54f2\u4e5f\u3001\u6749\u6d66\u3000\u5fb9\u3001\u9ed2\u6728\u3000\u8302\u3001\u6c34\u653f\u3000\u8c4a\u3001\u5ca9\u6fa4\u5b5d\u660c\u3001\u6cbc\u7530\u88d5\u4e00<br \/>\n\u30d3\u30bd\u30d6\u30ed\u30ed\u30fc\u30eb\u8cbc\u4ed8\u5264\u304c\u6709\u7528\u3067\u3042\u3063\u305f2\u4f8b<\/p>\n<\/section>\n<section>\n<h4>\u7b2c155\u56de\u65e5\u672c\u547c\u5438\u5668\u5185\u8996\u93e1\u5b66\u4f1a\u95a2\u6771\u652f\u90e8\u4f1a\u30002015.12.5 \uff08\u6771\u4eac\uff09<\/h4>\n<p>\u6e0b\u6fa4\u3042\u305a\u3055\u3001\u5c71\u53e3\u516c\u4e00\u3001\u5c71\u53e3\u3000\u5f69\u3001\u539f\u3000\u5065\u4e00\u90ce\u3001\u9234\u6728\u96c5\u6587\u3001\u5185\u7530\u3000\u6075\u3001\u5927\u5cf6\u4e00\u771f\u3001\u5897\u6e15\u88d5\u6717\u3001\u6885\u6d25\u548c\u6075\u3001\u524d\u91ce\u654f\u5b5d\u3001\u9808\u8cc0\u9054\u592b\u3001\u4e45\u7530\u525b\u5fd7<br \/>\n\u533a\u57df\u679d\u304b\u3089\u306e\u6c17\u9053\u72ed\u7a84\u3092\u8a8d\u3081\u305fABPA\u306e\u4e00\u4f8b<\/p>\n<\/section>\n<section>\n<h4>CVMW2015\u5fc3\u8840\u7ba1\u4ee3\u8b1d\u9031\u9593\uff08\u7b2c23\u56de\u65e5\u672c\u8840\u7ba1\u751f\u7269\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u3001\u7b2c19\u56de\u65e5\u672c\u5fc3\u8840\u7ba1\u5185\u5206\u6ccc\u4ee3\u8b1d\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\u3001\u7b2c32\u56de\u56fd\u969b\u5fc3\u81d3\u7814\u7a76\u5b66\u4f1a\u65e5\u672c\u90e8\u4f1a (ISHR\uff09\u3001\u7b2c37\u56de\u5fc3\u7b4b\u751f\u691c\u7814\u7a76\u4f1a\uff09\u30002015.12.10-12\uff08\u795e\u6238\uff09<\/h4>\n<p>1\uff09Sunaga\u3000H,Matsui H,Iso T,Matsuzaka T,Shimano H,Koitabashi N,Yokoyama T,Kurabayashi M.<br \/>\nThe fatty acid metabolism regulates phenotype of vascular smooth muscle cells via AMPK-KLF4 axis : Therapeutic implication for diabetic atherosclerosis.<\/p>\n<p>2\uff09Yogi U,Iso T,Mas Rizky A A S,Koitabashi N,Kurabahashi M.<br \/>\nEnhanced Glucose Uptake Exacerbates Rather than Prevents Heart Failure in Septic Mice Lacking Fatty Acid Binding Protein 4\/5<\/p>\n<p>3\uff09Koitabashi N,Seki M,Simon Conway,Furukawa N,Sunaga H,Yokoyama T,Kurabayashi M<br \/>\nInhibition of TGF \u03b2 signaling in perivascular periostin expressing cells attenuates the development of pulmonary arterial hypertension in mice<\/p>\n<p>4\uff09\u78ef\u3000\u9054\u4e5f\u3001\u30a6\u30f3\u30d0\u30e9\u30ef\u30f3 \u30e8\u30ae\u3001\u30b7\u30a2\u30e0\u30b9\u30ca\u30eb\u30ce\u30de\u30ba\u30ea\u30ba\u30ad\u30fc\u3001\u6c5f\u30ce\u6d66\u5408\u4f4d\u5b50\u3001\u5c0f\u5009\u6625\u6d77\u3001\u677e\u4e95\u5f18\u6a39\u3001\u6a2a\u5c71\u77e5\u884c\u3001\u5009\u6797\u6b63\u5f66<br \/>\n\u52d5\u8108\u786c\u5316\u5de3\u306b\u304a\u3051\u308b\u8102\u80aa\u9178\u7d50\u5408\u30bf\u30f3\u30d1\u30af4\/5\uff08FABP4\/<br \/>\n5\uff09\u306e\u767a\u73fe\u5206\u5e03\u3068\u8cc7\u8cea\u5206\u5e03\u3068\u306e\u95a2\u9023<\/p>\n<\/section>\n<section>\n<h4>\u7b2c620\u56de\u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u95a2\u6771\u5730\u65b9\u4f1a\u30002015.12.12\uff08\u6771\u4eac\uff09<\/h4>\n<p>\u9577\u5c3e\u666f\u5145\uff0c\u4e0a\u91ce\u3000\u5b66\uff0c\u539f\u7530\u76f4\u4e4b\uff0c\u4f50\u85e4\u9ebb\u91cc\uff0c\u6e05\u6c34\u96c4\u81f3\uff0c\u8302\u6728\u3000\u5145<br \/>\n\u591a\u767a\u9aa8\u8ee2\u79fb\u3067\u767a\u898b\u3055\u308c\u8840\u7403\u8caa\u98df\u75c7\u5019\u7fa4\u3092\u304d\u305f\u3057\u305f\u539f\u767a\u4e0d\u660e\u817a\u764c\u306e1\u4f8b\n<\/p>\n<\/section>\n","protected":false},"excerpt":{"rendered":"<p>\u7b2c235\u56de\u65e5\u672c\u5faa\u74b0\u5668\u5b66\u4f1a\u95a2\u6771\u7532\u4fe1\u8d8a\u5730\u65b9\u4f1a2015.2.7\uff08\u6771\u4eac\uff09 \u9f4b\u85e4\u771f\u8863\u3001\u8239\u7530\u7adc\u4e00\u3001\u9577\u8c37\u5ddd\u3000\u5bdb\u3001\u5f8c\u85e4\u6176\u5927\u3001\u5897\u7530\u304f\u306b\u5b50\u3001\u53cd\u753a\u79c0\u7f8e\u3001\u5c0f\u4fdd\u65b9\u3000\u512a\u3001\u4f50\u85e4\u4e07\u57fa\u4eba\u3001\u677e\u5c3e\u5f25\u679d\u3001\u4f50\u91ce\u5b8f\u548c\u3001\u9ad8\u9593\u5178\u660e\u3001\u7b20\u9593\u3000\u5468\u3001\u5c0f\u677f\u6a4b\u7d00\u901a\u3001\u5009\u6797\u6b63\u5f66 \u814e\u79fb [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":191,"menu_order":68,"comment_status":"closed","ping_status":"closed","template":"tpl_results.php","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-195","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/pages\/195","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=195"}],"version-history":[{"count":1,"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/pages\/195\/revisions"}],"predecessor-version":[{"id":196,"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/pages\/195\/revisions\/196"}],"up":[{"embeddable":true,"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/pages\/191"}],"wp:attachment":[{"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=195"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}